revealed that in nonalcoholic steatohepatitis (NASH), using a transgenic mouse model with hepatocyte specific Bcl-3 overexpression, hepatocyte-specific Bcl-3 directly accelerates hepatic steatosis and inflammation via insulin-sensitive metabolic transcription factors (88). Here, BCL3 is linked to fatty liver disease.